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  25 
Abstract 26 
 27 
The current trend in reducing the antibiotic usage in animal production imposes 28 
urgency in identification of novel biocides., The essential oil carvacrol for example 29 
changes the morphology of the cell and acts against a variety of targets within the 30 
bacterial membranes and cytoplasm and our in vitro results show that it reduces 31 
adhesion and invasion of chicken intestinal primary cells and also biofilm formation. 32 
A trial was conducted to evaluate the effects of dietary supplementation of carvacrol 33 
at 4 concentrations (0, 120, 200, and 300 mg/kg of diet) on Lactobacillus spp., E. 34 
coli, Campylobacter spp. and broilers performance. Each of the 4 diets was fed to 3 35 
replicates / trial of 50 chicks each from day 0 to 35. Our results show that carvacrol 36 
linearly decreased feed intake, feed conversion rates (FCR) and increased body 37 
weight (BW) at all levels of supplementation. Plate count analysis showed that 38 
Campylobacter spp., was only detected at 35 days in the treatment groups 39 
compared with the control group where the colonisation occurred at 21 days. The 40 
absence of Campylobacter spp., at 21 days in the treatment groups was associated 41 
with a significant increase in the relative abundance of Lactobacillus spp. Also, 42 
carvacrol was demonstrated to have a significant effect on Eschericia coli numbers 43 
in the caecum of the treatment groups, at all supplementation levels. In conclusion 44 
this study shows for the first time that at different concentrations of carvacrol can 45 
delay Campylobacter spp., colonisation of chicken broilers, by inducing changes in 46 
gut microflora, and demonstrates promise as an alternative to the use of antibiotics.  47 
 48 
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 50 
  51 
Introduction 52 
 53 
Since 2006 ban of antibiotics research has taken place to identify alternative 54 
substances which can be used to not only treat animal diseases but also to reduce 55 
the presence of pathogenic bacteria posing a threat to human health. Plant derived 56 
antimicrobials, also known as PDAs, are a suitable alternative to antibiotics as they 57 
do not cause resistance and side effects (Juneja and others 2012). The 58 
effectiveness of essential oils, like carvacrol, against pathogenic bacteria is 59 
expressed by the effects on outer and inner membrane integrity, virulence gene 60 
expression, biofilm formation all regulated through quorum sensing activities (Bassler 61 
2002). A major source of carvacrol is oregano oil, but it is also produced through 62 
biotechnological synthesis by genetically modified microorganisms. Its mechanism of 63 
action is not well studied (Lambert and others 2001), however it has been suggested 64 
that carvacrol disintegrates the outer membrane of pathogenic bacteria, increases 65 
permeability to ATP and depolarise the membranes (Xu and others 2008). Additional 66 
effects also show that it has a beneficial effect against chemically-induced colon 67 
carcinogenesis in rats (Sivaranjani and others 2016). 68 
 69 
Food-borne pathogens including Campylobacter spp., and E. coli are a concern for 70 
the poultry industry. Campylobacter jejuni, a microaerophilic bacterium, is well known 71 
for its ability to cause severe gastroenteritis and life-threatening diseases in humans 72 
and is considered a commensal in poultry (Crushell and others 2004). The main 73 
source of infections in humans is considered to be the consumption of improperly 74 
cooked chicken meat. The positive effect of carvacrol, in vitro, against 75 
Campylobacter spp., has been shown at concentrations of 7.8-800 µg/ml (Aslim and 76 
Yucel 2008) but the direct effect on virulence has only been described in INT-407 77 
cells and using C. jejuni 108, a human isolate (van Alphen and others 2012). Based 78 
on its antimicrobial proprieties, using carvacrol to modify the microbiota and reduce 79 
the presence of Campylobacter spp., in broilers caecum has gained increasing 80 
interest (Ozogul and others 2015). Meat quality can benefit from the inclusion of 81 
oregano oil in broiler diets and it has been reported that carvacrol can inhibit lipid 82 
oxidation in meat at concentrations of 50-100 mg/kg feed (Luna and others 2010). 83 
However, the industry is reluctant in relation to its applicability due to the fact that the 84 
literature lacks information in this area (Lillehoj and others 2011). Recent data shows 85 
that inclusion of encapsulated carvacrol, thymol, and limonene (up to 100 mg/kg) can 86 
improve performance as well as apparent ileal digestibility of nutrients in broilers 87 
(Hafeez and others 2015). 88 
 89 
The present manuscript describes the effect of carvacrol feeding on the 90 
microbiological composition of the caecal content in naturally colonized chicken 91 
broilers and investigates the dose effect of carvacrol on Campylobacter spp., E. coli 92 
and Lactobacillus with focus on key poultry performance indicators as well as meat 93 
quality. 94 
 95 
 96 
 97 
 98 
  99 
Material and Methods 100 
 101 
Broilers, diet and experimental design 102 
This study was carried out using a total of 600 Ross-308 male chicken broilers 103 
divided in 4 treatments (Control, T1, T2 and T3) with pens containing 50 birds/pen. 104 
The 4 treatments were fed with 120, 200 and 300 mg/kg feed of carvacrol. (Sigma, 105 
UK).  106 
 107 
Analysis of poultry growth and performance 108 
 109 
The performance parameters investigated were: body weight, feed intake, feed 110 
conversion ratio and broiler mortality rate. In order to analyse the economic 111 
efficiency of growth we have also calculated the European Broiler Index (EBI) and 112 
European Production Efficiency Factor (EPEF) (Broiler Management Manual Ross-113 
308 and Home page address: www.aviagen.com).  114 
 115 
Plate count enumeration of Campylobacter spp., and E. coli in broilers caeca 116 
 117 
For Campylobacter the enumeration method was based on those described in the 118 
British Standard BS EN ISO 10272:2006 and the enumeration of E. coli was based 119 
on the British Standard BS EN ISO16649-2:2001.   120 
 121 
DNA and RNA extraction  122 
 123 
Caecal DNA was extracted using the QIAamp DNA Stool Mini Kit according to the 124 
manufacturer’s instructions. Total RNA was isolated from the caecum, large and 125 
small intestine using Qiagen RNA extraction kit according to the manufacturer’s 126 
protocol. 127 
 128 
16S rRNA amplification and sequencing 129 
 130 
16S metagenomic sequencing library preparation was constructed using Illumina 131 
guidelines (Illumina, U.S.A). The 16S ribosomal primers used were V3 132 
(tcgtcggcagcgtcagatgtgtataagagacagcctacgggnggcwgcag) and V4 133 
(gtctcgtgggctcggagatgtgtataagagacaggactachvgggtatctaatcc) (Klindworth and others 134 
2013). A second PCR step was performed to attach dual indices and Illumina 135 
sequencing adapters using the Nextera XT Index kit (Table 2). Sequencing was 136 
performed on an Illumina MiSeq using a v3 150 bp paired-end kit. Initial data quality 137 
was assessed in FastQC (S 2010). Data was uploaded onto BaseSpace and 138 
analysed using the Qiime preprocessing and visualization apps (Caporaso and 139 
others 2010).  140 
 141 
qPCR for quantification of lactic acid bacteria 142 
 143 
The relative abundance of intestinal Lactobacillus in DNA isolated from broiler 144 
caecum was measured by qPCR on a 7900 Fast Real-Time System. The PCR 145 
reactions were set using SYBR Green Master mix (Applied Biosystems) and 146 
bacterial 16S group-specific primers (All Lactobacillus Forward 5’-147 
AGGGTGAAGTCGTAACAAGTAGCC-3’ and All Lactobacillus Reverse 5’- 148 
CCACCTTCCTCCGGTYYGTCA – 3’).  149 
 150 
Mucin mRNA analysis 151 
 152 
The RT-PCR was carried as previously described (Smirnov and others 2005). 153 
Briefly, chicken mucin primers F 5′-GCTGATTGTCACTCACGCCTT-3′, R 5′-154 
ATCTGCCTGAATCACAGGTGC-3′) and primers from the Gallus gallus 18S 155 
ribosomal RNA gene F: 5′-CGATGCTCTTAACTGAGTGT-3′ and R: 5′-156 
CAGCTTTGCAACCATACTC-3′ were used.  157 
 158 
Histology 159 
 160 
Gastrointestinal tract samples (colon, small intestine and cecum) were placed in 161 
Carnoy's solution, at 4ºC until processing. Following fixation the tissue samples were 162 
stained with hematoxylin (7 min) and eosin (3 min). The stained slides were 163 
dehydrated (70%IMS-1 min, 95% IMS-2 min, 100% IMS-2 min), cleared in xylene 164 
(30 min) and mounted in DPX medium. Slides were analysed under a brightfield 165 
microscope (Leica DMLB). Images were acquired using a Leica DFC300x camera 166 
and the IM50 imaging software (Pircalabioru and others 2016). 167 
 168 
Biofilm assay 169 
 170 
The biofilm assay was performed as previously described (Reuter and others 2010). 171 
Briefly, C. jejuni RC039 was grown in Mueller Hinton medium containing 120 mg/ml, 172 
200 mg/ml and 300 mg/ml carvacrol diluted in ethanol and added to the growth 173 
medium in polystyrene flatbottomed 6 well plates and incubated for 48 hours at 174 
42°C. One milliliter of a 1% crystal violet solution was added and the wells were 175 
incubated at room temperature for 60 min. Unbound crystal violet was washed off 176 
with water and the plates were dried at 37°C. Bound crystal violet was dissolved in 177 
20% acetone in ethanol for 10 min and was then poured into cuvettes, and the A590 178 
was measured. 179 
 180 
Infection of chicken primary intestinal cells 181 
 182 
The gentamicin protection assay (Corcionivoschi and others 2009) was used to 183 
determine the effect of carvacrol on the virulence of C. jejuni RC039. Briefly, chicken 184 
intestinal primary cells were isolated as previously described (Byrne and others 185 
2007). Plate grown C. jejuni RC039 was washed and re-suspended in tissue culture 186 
medium at an OD600 of 0.4. Cells were washed with PBS, and 2 ml of fresh culture 187 
medium containing DMSO or DMSO + carvacrol was added to each well (120mg/ml, 188 
200mg/ml and 300mg/ml) (Qiu and others 2010). The error bars represent standard 189 
deviations for three separate wells. The significance of differences in adhesion and 190 
invasion between samples was determined using the Student t test. A P-value of 191 
<0.05 was defined as significant. 192 
 193 
TBARS 194 
 195 
Lipid oxidation was evaluated by determining the thiobarbituric acid reactive 196 
substances as previously described (Cherian and others 2002). The meat sample (5 197 
g) was homogenized with 15 ml of deionized distilled water for 10 seconds. To the 198 
meat homogenate butylated hydroxyanisole (50 μl, 10%) and thiobarbituric 199 
acid/trichloroacetic acid (TBA/TCA, 2 ml) were added. The absorbance of the 200 
resulting supernatant solution was determined at 531 nm against a blank containing 201 
1 ml of double distilled water (DDW) and 2 ml of TBA/TCA solution. The amounts of 202 
TBARS were expressed as milligrams of malondialdehyde per kilogram of meat. 203 
 204 
Gas Chromatography (GC) for fatty acids analysis 205 
 206 
For GC analysis of fatty acids 1 g of meat sample was mixed with 3 ml methanol and 207 
0.7 ml 10NKOH and incubated at 56°C oven overnight. An internal standard 208 
(Tridecanoic acid) was added to check recovery. The sample was allowed to cool 209 
before adding 0.58ml 24N H2SO4 followed by 90 minutes incubation, with occasional 210 
mixing. Once cooled 3 ml of hexane was added and the sample was mixed. The 211 
extract was run for 91 minutes to ensure all FAMEs (fatty acid methyl esters) were 212 
recovered. These were then identified and analysed accordingly using the GC 213 
(Varian 3800 GC). 214 
 215 
  216 
Results 217 
 218 
Effects of carvacrol on cell invasion and biofilm formation in vitro 219 
 220 
In order to reduce pathogen colonisation of the broiler gastrointestinal tract, any 221 
antimicrobial used will have to reduce the capacity of this bacterium to adhere to and 222 
invade the gastrointestinal mucosa. Therefore we have first investigated, in vitro, the 223 
efficacy of carvacrol (120, 200 and 300 mg/kg feed) in preventing the colonisation 224 
and infection of a C. jejuni chicken isolate to infect chicken primary intestinal cells. 225 
Our results show for the first time (Figure 1, Panels A and B) that following 226 
gentamicin protection assay both the adhesion (p<0.0001) and invasion (p<0.0001) 227 
of C. jejuni RC039 to chicken intestinal primary cells were reduced significantly when 228 
inoculated in the presence of carvacrol. Moreover carvacrol also significantly 229 
reduced the ability of C. jejuni RC039 to form biofilms (Figure 1, Panel C).  230 
 231 
Carvacrol effect on the chicken gastrointestinal compartments 232 
 233 
Next we investigated the effect of carvacrol on the integrity and development of the 234 
intestinal surfaces directly involved in bacterial colonisation and nutrient absorption. 235 
The hystologic analysis at slaughter indicate an increase in small intestinal villus 236 
height in all carvacrol groups (Figure 1). Similar investigations performed on tissue 237 
harvested from the large intestine also revealed healthier epithelial surfaces in the 238 
experimental groups compared to the control (Figure 1, Panel G and H). Changes 239 
were observed in the caecum, however clear erythrocyte infiltrations (as indicated by 240 
the yellow arrow in Figure 1, Panel I were observed in the control group and absent 241 
in the experimental (Figure 1, Panel J). In order to investigate if the increase in 242 
epithelial surface in the experimental groups was associated with increased mucus 243 
production we have investigated the presence of mucin mRNA (Figure 1, Panel D). 244 
The expression of mucin mRNA increased gradually and significantly in the 245 
experimental groups compared to the control in both large and small intestine. In the 246 
caecum similar increases were observed in mRNA expression; however significance 247 
was only detected in experimental group T3. These results suggest that carvacrol 248 
can increase the epithelial surface and the production of the inner mucus layer.  249 
 250 
Carvacrol delays Campylobacter spp., detection in naturally colonized chicken 251 
broilers  252 
 253 
Our results show (Figure 2, Panel D) that during the starter (0-10 days) and grower 254 
periods (11-21 days) the relative abundance of Lactobacillus spp. in broilers caecal 255 
content is significantly increased compared to the control group, and that the E. coli 256 
presence (Figure 2, Panel C by plate count) is significantly reduced in all three 257 
experimental groups compared to the control. This increase in Lactobacillus 258 
presence is also associated with lack of Campylobacter spp., detection at 10 and 21 259 
days in all the experimental groups (Figure 2, Panel A and B). The presence of 260 
Campylobacter spp., in the treatment groups (T1, T2 and T3) only occurs at day 35 261 
when the abundance of Lactobacillus sp. decreases below the levels of the control 262 
group. Our results suggest that carvacrol can stimulate the increase in abundance of 263 
probiotic bacteria in broilers caecum and reduce Campylobacter spp., presence up 264 
to 31% at levels of supplementation of 120 mg/kg feed. 265 
 266 
Carvacrol induces changes in chicken caecum microbiota 267 
 268 
The chicken caecum microbiome was assessed at Day 10, 21 and 35. The major 269 
phyla were the Firmicutes (65.49%), Proteobacteria (28.24%) and Bacteroidetes 270 
(6.13%). In Day 10 Carvacrol samples, T1 (89.9%), T2 (83.7%) and T3 (82.7%) 271 
displayed a higher percentage of Firmicutes when compared to Day 10 control 272 
sample (65.5%). Analysis of the Day 21 samples displays the presence of the three 273 
major Phyla, however the percentage of Bacteroidetes has increased in all Day 21 274 
samples; C (47.2%), T1 (39.4%), T2 (34.9%) and T3 (55.8%). At Day 35 taxonomic 275 
analysis at the class level further identified differences between the samples. Further 276 
investigation of the Firmicutes identified a higher percentage of Bacilli within the 277 
Carvacrol samples. Further analysis of the Proteobacteria distribution identified the 278 
presence of Epsilonproteobacteria in Day 35 control and Carvacrol samples (T1, T2 279 
and T3). The Day 35 control samples contained Campylobacter spp., at 10.52%. 280 
This was higher than Day 35 Carvacrol samples T1 (6.43%) and T2 (7.85%), 281 
however the Day 35 Carvacrol T3 percentage Campylobacter spp., was noted to be 282 
higher (13.86%) than the respective Day 35 control sample.  283 
 284 
Carvacrol improves production parameters at slaughter 285 
 286 
The feed intake (Figure 4, Panels A and B) for the experimental broilers in group T1 287 
was slightly higher (+1.58%) compared to the control but the increase was not 288 
statistically significant. The feed conversion rates were also reduced by 6.7% in 289 
experimental group T1 (NS), by 24.8% (p=0.04) at T2 and by 17.5% (p=0.09) at T3 290 
(Figure 4, Panels C and D). As shown in Figure 4, Panels E and F at Day 35 291 
(slaughter) a 5.45% increase in body weight was recorded for experimental group T1 292 
(p=0.02), a 5.10% increase for T2 (p=0.03) and 4.08% increase for T3 (p=0.02). The 293 
experimental group T2 reduced its feed intake by 12.9% (p=0.006) and T3 by 6.29% 294 
(p=0.04) compared to the control at 35 Days.  295 
 296 
Lipid oxidation and fatty acid composition of broiler thigh muscle 297 
 298 
Across the carvacrol treatments the TBARS values decreased significantly only at 21 299 
days as shown in figure 4 (Panel G and H). Treatment T1 showed a 19.18% 300 
decrease (p=0.2), at treatment T2 the TBRAS were reduced with 57.38% (p=0.02) 301 
and with 22.57% at T3 (p=0.09). At Day 35 compared to the control group, an 8.68% 302 
increase in total ω3 fatty acids, 9.34% increase in ω6, 13.77% increase in ω7 and 303 
8.43% in ω9. The total mono-unsaturated fatty acids (MUFA) at Day 35 showed an 304 
increase of 8.55% over control and the poly-unsaturated fatty acids (PUFA) 305 
increased by 9.24% compared to the control. The SFA increases in T2 (1 mg/g 306 
muscle) and T3 (1.46 mg/g) muscle are not significant and probably not biologically 307 
relevant. However, there was an increase by 2.11 mg/g muscle in UFA at T2 and by 308 
0.6 mg/g muscle at T3 with no statistical significance as described in Supplementary 309 
Table 1.  310 
 311 
  312 
Discussion 313 
 314 
The most recent report from the European Food Safety Authority (EFSA) places 315 
Campylobacter spp., as the most commonly reported human gastrointestinal 316 
pathogen in European Union with 214,000 cases and 56 deaths recorded in 2013 317 
(Authority 2015). This manuscript describes for the first time the effect of Carvacrol in 318 
preventing adhesion and invasion of chicken intestinal primary cells and also new 319 
data on chicken broiler microbiota composition, growth performance and 320 
Campylobacter spp., presence in a farm set up using naturally colonized broilers. 321 
 322 
It is known that essential oils such as Carvacrol act by increasing the membrane 323 
permeability of Gram-negative bacteria, causing structural and functional changes 324 
leading to outer membrane disintegration (La Storia and others 2011). The structural 325 
and functional integrity of C. jejuni outer membrane structures have been previously 326 
described as crucial for this pathogen to efficiently attach and adhere to gut epithelial 327 
cells (Corcionivoschi and others 2012). The ability of C. jejuni to colonise or to infect 328 
the epithelium is highly dependent on the genetic specificity of each strain 329 
(Ragimbeau and others 2014). In order to reduce this variability we have used C. 330 
jejuni RC039, a highly virulent chicken isolate recently described as positive for the 331 
newly identified Type Six Secretion System (T6SS) (Corcionivoschi and others 332 
2015). Carvacrol was proven to efficiently reduce the pathogenicity of this isolate 333 
when tested on chicken intestinal primary cells. Moreover, because the outer 334 
membrane structures are involved in the ability of C. jejuni to create biofilm (Naito 335 
and others 2010) we have shown that carvacrol has a negative effect on the ability of 336 
C. jejuni RC039 to from, biofilm . 337 
 338 
As described above it is clear that Carvacrol can reduce the attachment of C. jejuni 339 
to chicken intestinal cells (K. Arsi and Donoghue 2014), however if this is also the 340 
case of an in vivo scenario on naturally colonized chicken broilers is still under 341 
debate. It has been suggested that probiotic bacteria are very efficient in reducing C. 342 
jejuni colonisation of the gastrointestinal compartments in chicken broilers, however 343 
in this case the probiotic strains were introduced in the diets and the authors have 344 
not characterised the microbiota composition in the caecum (Cean and others 2015). 345 
We have shown that up to Day 21 Carvacrol was able to increase the presence of 346 
probiotic bacteria which correlates with no C. jejuni presence in the experimental 347 
groups.  348 
 349 
Dietary evaluation of essential oils has been indicated to reduce the gut lesions and 350 
improve villus height and crypt depth in the small intestine of broiler chickens fed 351 
with 120-240 mg/kg tymol and carvacrol. It has been suggested that these essential 352 
oils improve intestinal integrity and modulate immune responses in Clostridium 353 
perfrigens challenged chicken broilers (Du and others 2016). Also, an increased 354 
villus height is associated with an increased digestive and absorptive function of the 355 
gut due to increased absorptive surface area, enzyme expression and nutrient 356 
transport system (Amat and others 1996). We are now showing, in vivo, that 357 
carvacrol supplementation through feed, improves the expression of mucin mRNA 358 
expression in all the essential gut compartments providing a possible explanation for 359 
the increase in production parameters.  360 
 361 
The high content of polyunsaturated fatty acids (PUFA) makes poultry meat less 362 
susceptible to oxidative deterioration (Luna and others 2010). In our study we found 363 
that PUFA was 5.93% in birds fed 120 mg/kg feed of carvacrol, suggesting an 364 
increase in meat quality and subsequently in shelf life. The reduced feed intakes 365 
observed during the trial could be explained by the enhanced release of satiety 366 
hormones, an effect previously described in rats (Yang and others 2013). The 367 
consumer will benefit from having a product with increased ω7 concentration as it 368 
has been previously shown that it may be useful in the treatment of 369 
hypertriglyceridemia with the beneficial added effects of decreasing LDL and hs-CRP 370 
and raising HDL (Bernstein and others 2014). 371 
 372 
We have demonstrated that carvacrol prevented the infection of chicken primary 373 
intestinal cells in vitro and it is also able to prevent campylobacters to form biofilm. 374 
Our plate count data also indicates that carvacrol affects Campylobacter spp., 375 
colonisation in vivo and our study indicates the efficient concentrations. Finally, our 376 
results indicate that, at farm level, inclusion of carvacrol can improve poultry health, 377 
feed efficiency, meat quality and delay colonization of foodborne pathogenic bacteria 378 
in broiler chickens  379 
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 477 
Table 1. Chemical composition of basal diet 478 
Item 
Starter 
0-10 days 
Grower 
(11-24 days) 
Finisher 
(25-35) days 
    
Wheat 54.623 57.553 61.300 
Full fat soya 12.000 12.000 12.000 
Brazilian GM  hipro 25.000 21.000 17.000 
Lime bulk 0.717 0.700 0.500 
DCP bulk (18.1% p) 1.654 2.000 2.150 
Salt bulk 0.200 0.200 0.200 
Sod.bi-carbonate 0.199 0.166 0.162 
DL methionine 0.487 0.435 0.378 
L-lysine 0.373 0.318 0.281 
Threonine 0.247 0.128 0.029 
Vitamin+mineral 
premix 0.500 0.500 0.500 
Soyabean oil 4.000 5.000 5.500 
Calculated composition (%)    
ME Kcal/kg 2999 3081 3133.8 
CP 23.12 21.53 20.04 
Lys 1.45 1.308 1.17 
Met+Cys 1.089 0.996 0.91 
Ca 0.97 0.906 0.85 
AvP 0.49 0.41 0.409 
 479 
 480 
  481 
 482 
Table 2. Samples used in study and corresponding I7 and I5 index primer used in this study. 483 
Sample Name I7 Index ID Index I5 Index ID Index 2 
Day10C N709 GCTACGCT S502 CTCTCTAT 
Day10T1 N710 CGAGGCTG S517 GCGTAAGA 
Day10T2 N707 CTCTCTAC S502 CTCTCTAT 
Day10T3 N708 CAGAGAGG S502 CTCTCTAT 
Day21C N711 AAGAGGCA S517 GCGTAAGA 
Day21T1 N712 GTAGAGGA S517 GCGTAAGA 
Day21T2 N701 TAAGGCGA S502 CTCTCTAT 
Day21T3 N702 CGTACTAG S502 CTCTCTAT 
Day35C N703 AGGCAGAA S502 CTCTCTAT 
Day35T1 N704 TCCTGAGC S502 CTCTCTAT 
Day35T2 N705 GGACTCCT S502 CTCTCTAT 
Day35T3 N706 TAGGCATG S502 CTCTCTAT 
 484 
 485 
 486 
  487 
Figure captions 488 
 489 
Figure 1. Adhesion, internalization, biofilm formation in vitro, and in vivo mucin 490 
expression 491 
 492 
Panel A shows the adhesion and Panel B the invasion of chicken intestinal primary 493 
cells of C. jejuni RC039 in the presence of Carvacrol. Panel C shows the effect on 494 
biofilm formation. Panel D, mucin mRNA expression. Micrographs of epithelial 495 
integrity and villus height of small intestine (Panel E control, F - experimental) large 496 
intestine (Panel G control group, H – experimental) and caecum (Panel I control, J 497 
experimental). Yellow arrow indicates erythrocyte infiltration in the lamina propria in 498 
the control group sections. Bar = 10µm. The experiments were done in triplicate and 499 
on three separate occasions. Significance was assessed by Student’s t test. 500 
(**P<0.05, P<0.005, ***P<0.0005).  501 
 502 
Figure 2. Campylobacter spp., Lactobacillus spp. and E. coli quantification in caecal 503 
content at 10, 21 and 35 days.  504 
 505 
Panel A shows the Campylobacter spp. counts from the experimental groups (T1, T2 506 
and T3) at 0-35 days. The percentage change over control is presented in Panel B. 507 
The data presented was obtained from 12 broilers/experiment (n=48/each time 508 
point). The E. coli counts have shown significant decrease at 35 days in all 509 
experimental groups (Panel C).. The P values were calculated relative to the count 510 
obtained at 21 days. Error bars represent ±S.D. of 12 broilers/experiment (n=48/each 511 
time point). Statistical significance (Student’s t test) relative to the level of control 512 
group is indicated. The relative abundance of Lactobacillus spp. as determined by 513 
qPCR (Panel D) from broilers cecal DNA. Each stacked bar represents the mean 514 
relative abundance; Eubacteria 16S was used for normalization. Error bars represent 515 
±S.D. of 12 broilers/experiment (n=48/each time point). Statistical significance 516 
(Student’s t test) relative to the level of control group is indicated. 517 
 518 
Figure 3. Plot bar charts of bacteria classified as phyla (A), class (B) and order (C) 519 
detected from microbiome studies. Percentage distribution for phyla and all the other 520 
levels in Supplementary Fable 1. Data was generated by uploading onto BaseSpace 521 
and analysed using the Qiime preprocessing and visualization apps. 522 
 523 
Figure 4. The effect of Carvacrol on the production parameters of naturally colonized 524 
chicken broilers 525 
 526 
Panel A describes the effect of Carvacrol on broiler feed intake profile from 0-35 527 
days and Panel B the percentage change in feed intake relative to the control group. 528 
The feed conversion rates (FCR) are shown in Panel C and the percentage change 529 
over control in Panel D. The body weight profiles between the experimental groups 530 
are indicated in panel E and F. Lipid oxidation is presented in Panel G at 21 and 35 531 
days for each experimental group and in Panel H the data is expressed as % TBARS 532 
inhibition compared to control. Statistical significance (Student’s t test) relative to the 533 
control group feed intake is indicated. 534 
 535 
  536 
Supplementary Table S1 537 
Fatty acid composition of meat samples 538 
 539 
 540 
 541 
 542 
Specific
ations 
Total 
SFA  
Total 
UFA 
Total 
MUFA 
Total 
PUFA 
Total 
ω3 
Total 
ω6 
Total 
ω7 
Total 
ω9 
mg/g muscle 
Control 18.51 53.20 20.99 31.10 3.57 27.53 1.67 19.25 
T1 16.90 50.04 19.53 29.47 3.36 26.10 1.71 17.74 
T2 19.51 55.31 23.07 31.18 3.62 27.56 2.13 20.87 
T3 19.97 53.80 22.79 33.98 3.88 30.11 1.9 20.87 
Significa
nce NS NS NS NS NS NS NS NS 
Fold increase over control 
T1 vs C 
0.91338
0155 
0.94066
7878 
0.93014
7642 
0.94759
9657 
0.94117
6471 
0.94806
9241 
1.02594
8104 
0.92174
5152 
T2 vc C 
1.05438
5017 
1.03972
1822 
1.09890
4588 
1.00246
4638 
1.01493
9309 
1.00084
7355 
1.27744
511 
1.08431
4404 
T3 vs C 
1.07905
6366 
1.01134
0142 
1.08556
9138 
1.09247
7497 
1.08683
4734 
1.09345
1156 
1.13772
4551 
1.08431
4404 
Percentage increase over control 
T1 vs C 
-
8.66198
4513 
-
5.93321
2205 
-
6.98523
5752 
-
5.24003
4291 
-
5.88235
2941 
-
5.19307
5899 
2.59481
0379 
-
7.82548
4765 
T2 vc C 
5.43850
1711 
3.97218
2194 
9.89045
8803 
0.24646
3781 
1.49393
0906 
0.08473
5504 
27.7445
1098 
8.43144
0443 
T3 vs C 
7.90563
6593 
1.13401
416 
8.55691
3796 
9.24774
9679 
8.68347
3389 
9.34511
5603 
13.7724
5509 
8.43144
0443 
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